Chronic Pediatric Conditions - USMLE Step 2

  1. An 8-year-old boy with repaired Tetralogy of Fallot is doing well but has not had dental care in 2 years. Parents ask about preventing heart infection. Echocardiogram is stable; no cyanosis. Which of the following is the next best step in management?
    Answer: Recommend routine dental care and clarify that antibiotic prophylaxis is only indicated for specific high-risk cardiac lesions/procedures This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on repaired Tetralogy of Fallot. Effective management involves targeted endocarditis prophylaxis education. In this vignette, stable status, delayed dental care, and parental concerns about infection highlight the management challenges and considerations for repaired Tetralogy of Fallot. Choice A is correct because it aligns with current clinical guidelines limiting prophylaxis to high-risk cases. Choice B is incorrect because daily antibiotics are unnecessary and promote resistance. To improve understanding, clinicians should promote preventive care, focusing on key management principles like risk stratification and hygiene.
  2. A 14-year-old girl with stage 3 CKD has 3 months of worsening pruritus and bone aches. Labs: phosphorus 6.5 mg/dL, Ca 8.4 mg/dL, PTH elevated; creatinine stable. She admits skipping phosphate binders because they are "too many pills," and her diet is high in cola and packaged snacks. What is the next best step in management?
    Answer: Reinforce low-phosphate diet, optimize phosphate binder adherence, and coordinate with a renal dietitian This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on chronic kidney disease (CKD). Effective management involves dietary control and binder adherence for hyperphosphatemia. In this vignette, pruritus, bone aches, elevated phosphorus, PTH, skipped binders, and high-phosphate diet highlight the management challenges and considerations for CKD. Choice B is correct because it aligns with current clinical guidelines for low-phosphate diet and binder optimization. Choice A is incorrect because increasing phosphate worsens bone disease. To improve understanding, clinicians should involve dietitians for counseling, focusing on key management principles like electrolyte monitoring and symptom management.
  3. A 12-year-old girl with type 1 diabetes has 3 months of hyperglycemia and missed boluses; HbA1c 10.1%. She reports conflict at home and feels "burned out." She uses basal-bolus injections but checks glucose only once daily. No infection symptoms. Which of the following is the next best step in management?
    Answer: Screen for depression/diabetes distress and connect family with a diabetes care team to support adherence This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on type 1 diabetes. Effective management involves screening for distress and team support. In this vignette, hyperglycemia, missed boluses, high HbA1c, home conflict, and burnout highlight the management challenges and considerations for type 1 diabetes. Choice B is correct because it aligns with current clinical guidelines for addressing psychosocial barriers. Choice A is incorrect because increasing basal insulin ignores adherence issues. To improve understanding, clinicians should use validated screening tools, focusing on key management principles like holistic care and family involvement.
  4. An 8-year-old boy with repaired Tetralogy of Fallot presents for routine follow-up. Over 6 months he has reduced exercise tolerance and mild palpitations. Echocardiogram shows severe pulmonary regurgitation with right ventricular dilation; oxygen saturation 98% at rest. He takes no daily cardiac medications and has missed two cardiology visits due to transportation issues. What is the next best step in management?
    Answer: Arrange timely cardiology evaluation for pulmonary valve replacement consideration and obtain ambulatory rhythm monitoring This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on repaired Tetralogy of Fallot. Effective management involves lifelong cardiology surveillance, monitoring for complications like pulmonary regurgitation, and addressing access barriers. In this vignette, reduced exercise tolerance, palpitations, severe pulmonary regurgitation, RV dilation, and missed visits due to transportation highlight the management challenges and considerations for repaired Tetralogy of Fallot. Choice C is correct because it aligns with current clinical guidelines for timely evaluation for valve replacement and rhythm monitoring in symptomatic patients. Choice A is incorrect because reassurance without intervention ignores progressive symptoms and risks further deterioration. To improve understanding, clinicians should emphasize regular follow-up and symptom recognition, focusing on key management principles like early intervention for arrhythmias and valvular issues.
  5. Which vaccination strategy is most appropriate before his next infliximab infusion?
    Answer: Administer the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for enhanced coverage When managing patients starting TNF-α inhibitors like infliximab, you must prioritize vaccination strategies that maximize protection while accounting for immunosuppression. These patients have increased infection risk, particularly from encapsulated bacteria and opportunistic pathogens. The correct approach is administering PPSV23 (answer B). TNF-α inhibitors significantly impair immune responses to Streptococcus pneumoniae, making pneumococcal disease prevention critical. PPSV23 provides broader serotype coverage (23 vs 13 serotypes in PCV13) and should be given before starting biologics when possible, as vaccine efficacy decreases once immunosuppression begins. Answer A contains a critical error - while checking varicella immunity is appropriate, you shouldn't "defer live vaccines indefinitely." Live vaccines should be avoided during biologic therapy but can be given before starting treatment if immunity is lacking. Answer C suggests meningococcal B vaccine, but this patient already received meningococcal conjugate vaccine. While MenB could be considered, pneumococcal vaccination takes higher priority given the specific pneumococcal infection risk with TNF-α inhibitors. Answer D is completely wrong - TNF-α inhibitors don't "completely impair" vaccine responses. While responses are diminished, vaccination (especially with inactivated vaccines) still provides meaningful protection and is strongly recommended. Key strategy: For biologic therapy questions, remember the vaccination hierarchy: complete all indicated inactivated vaccines before starting treatment, with pneumococcal vaccines being highest priority for TNF-α inhibitor patients. Live vaccines must be avoided during therapy but can be given beforehand if needed.
  6. Which of the following is the most appropriate next step in long-term management to improve this patient's asthma control?
    Answer: Add a long-acting inhaled β2-agonist in a fixed-dose combination with his current low-dose corticosteroid When managing pediatric asthma, you need to assess current control and follow stepwise treatment guidelines. This patient shows signs of inadequate control despite being on Step 2 therapy: daytime symptoms 4 days/week (should be ≤2 days), nocturnal awakenings twice monthly (should be ≤1/month), and peak flow at 70% of personal best (should be >80%). The correct approach is B) Add a long-acting inhaled β2-agonist in a fixed-dose combination with his current low-dose corticosteroid. This represents Step 3 therapy per NHLBI guidelines. The combination of low-dose ICS + LABA is more effective than increasing ICS dose alone and has become the preferred step-up approach for inadequate control on low-dose ICS monotherapy. A represents an alternative Step 3 option, but medium-dose ICS monotherapy is less effective than the ICS/LABA combination and associated with higher risk of growth suppression in children. C is inappropriate because leukotriene receptor antagonists are less effective than ICS as controller therapy. You never discontinue effective controller medication (his ICS) when stepping up treatment. D suggests theophylline, which has a narrow therapeutic window, significant drug interactions, and side effects. It's considered an alternative add-on therapy only when preferred options aren't suitable. Study tip: Remember the asthma stepwise approach - when control is inadequate on low-dose ICS, the preferred step-up is adding LABA, not increasing ICS dose. Always assess control using the triad: symptoms, night awakenings, and peak flow/FEV1.
  7. A 14-year-old girl with stage 3 CKD has 2 months of poor growth and low energy. Labs: HCO3− 16 mEq/L, K 5.2 mEq/L; creatinine stable. She dislikes sodium bicarbonate tablets and often skips them. Family reports limited funds for alternative formulations. What is the most appropriate adjustment to the current treatment plan?
    Answer: Treat metabolic acidosis by improving alkali therapy adherence using a tolerable regimen and close follow-up This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on chronic kidney disease (CKD). Effective management involves optimizing alkali therapy for acidosis. In this vignette, poor growth, low energy, low bicarbonate, stable creatinine, skipped tablets, and limited funds highlight the management challenges and considerations for CKD. Choice A is correct because it aligns with current clinical guidelines for improving adherence to correct acidosis. Choice B is incorrect because increasing acid load worsens growth issues. To improve understanding, clinicians should explore alternative formulations, focusing on key management principles like growth monitoring and cost-effective care.
  8. Which long-term strategy is most appropriate to prevent further joint damage?
    Answer: Switch to prophylactic recombinant factor VIII infusions three times weekly When you encounter severe hemophilia A with recurrent joint bleeding, think about the shift from reactive to preventive care. This patient's pattern of 5 joint bleeds per year with developing joint damage signals the need for prophylactic management rather than continuing on-demand treatment. Choice A is correct because prophylactic factor VIII infusions maintain baseline clotting factor levels, preventing spontaneous bleeding episodes that cause progressive joint damage (hemophilic arthropathy). Three-times-weekly dosing provides adequate coverage to keep factor VIII levels above the critical 1% threshold that prevents spontaneous bleeding. This approach dramatically reduces annual bleeding episodes and preserves joint function long-term. Choice B fails because desmopressin only works in mild hemophilia A by releasing stored factor VIII from endothelial cells. In severe hemophilia (<1% baseline), there's insufficient factor VIII to release, making desmopressin ineffective. Choice C represents a fundamental misunderstanding of hemophilic joint damage. Methotrexate targets inflammatory arthritis, but hemophilic arthropathy results from recurrent hemarthroses causing iron deposition and cartilage destruction—not primary synovial inflammation. Treating the wrong pathophysiology won't prevent bleeding. Choice D is counterproductive because complete activity restriction leads to muscle weakness and actually increases bleeding risk. Appropriate physical activity with prophylactic coverage strengthens periarticular muscles that protect joints. For USMLE Step 2, remember that severe hemophilia management has evolved from on-demand to prophylactic therapy. When you see recurrent joint bleeding with early arthropathy signs, prophylaxis is the standard of care to prevent irreversible joint damage.
  9. An 8-year-old boy with repaired Tetralogy of Fallot is asymptomatic but has missed follow-up for 2 years. Echocardiogram now shows moderate pulmonary regurgitation and mild right ventricular enlargement. Parents report difficulty understanding prior instructions. What is the most appropriate adjustment to the current treatment plan?
    Answer: Schedule regular congenital cardiology surveillance and provide clear, language-appropriate follow-up instructions This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on repaired Tetralogy of Fallot. Effective management involves regular surveillance and clear communication. In this vignette, asymptomatic status, missed follow-up, moderate regurgitation, RV enlargement, and instruction misunderstandings highlight the management challenges and considerations for repaired Tetralogy of Fallot. Choice B is correct because it aligns with current clinical guidelines for lifelong cardiology monitoring. Choice A is incorrect because ongoing follow-up is essential despite well-being. To improve understanding, clinicians should use simple language and reminders, focusing on key management principles like complication prevention and patient education.
  10. A 14-year-old girl with stage 3 CKD has 6 weeks of muscle cramps and fatigue. Labs: K 5.5 mEq/L, HCO3− 17 mEq/L, phosphorus 6.2 mg/dL. She reports taking sodium bicarbonate "only when she remembers" and frequently eats processed foods. She is on lisinopril for proteinuria. Which of the following is the most likely cause of the patient's current symptoms?
    Answer: Metabolic acidosis from CKD worsened by poor bicarbonate adherence This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on chronic kidney disease (CKD). Effective management involves identifying metabolic derangements and improving adherence. In this vignette, muscle cramps, fatigue, hyperkalemia, acidosis, hyperphosphatemia, poor bicarbonate adherence, and processed food intake highlight the management challenges and considerations for CKD. Choice A is correct because it aligns with current clinical guidelines linking acidosis from nonadherence to symptoms. Choice B is incorrect because no fever or infection signs are present, making bacterial causes unlikely. To improve understanding, clinicians should educate on acid-base balance, focusing on key management principles like dietary restrictions and medication compliance.
  11. What is the most appropriate management at this time?
    Answer: Schedule elective pulmonary valve replacement to prevent further RV dilation When evaluating patients with repaired tetralogy of Fallot, you must monitor for progressive pulmonary regurgitation and its impact on right ventricular function. The key is recognizing objective thresholds that indicate intervention is needed, even in asymptomatic patients. This patient demonstrates clear progression: moderate pulmonary regurgitation with normal RV size has evolved to severe regurgitation with significant RV dilation (end-diastolic volume index 160 mL/m² vs normal <110) and early dysfunction (mildly reduced ejection fraction). These objective parameters indicate hemodynamically significant disease requiring intervention. Option A is correct because current guidelines recommend pulmonary valve replacement when RV end-diastolic volume index exceeds 150-160 mL/m² or when RV function begins declining, even in asymptomatic patients. Early intervention prevents irreversible RV dysfunction and preserves long-term outcomes. Option B is wrong because ACE inhibitors have no proven benefit for RV volume overload from pulmonary regurgitation. The primary issue is valve incompetence, not afterload. Option C represents dangerous delayed management. Waiting 3 years with already-established criteria for intervention risks irreversible RV dysfunction. The "wait and see" approach is only appropriate when objective thresholds haven't been met. Option D incorrectly focuses on activity restriction rather than addressing the underlying pathology. Sports restriction might be considered post-operatively but doesn't solve the progressive RV dilation. Remember: In congenital heart disease follow-up, objective imaging parameters trump symptoms. Asymptomatic patients can still require intervention based on quantitative criteria that predict future complications.
  12. A 12-year-old girl with type 1 diabetes has morning hyperglycemia (200–280 mg/dL) for 3 weeks; HbA1c 8.8%. She takes glargine at bedtime and rapid-acting insulin with meals; she reports consistent dosing but frequent late-night snacking without bolus insulin. Parents are recently divorced, and supervision is inconsistent. What lifestyle modification should be recommended?
    Answer: Add a planned bedtime snack with appropriate carbohydrate counting and bolus coverage or avoid unbolused snacks This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on type 1 diabetes. Effective management involves lifestyle adjustments, bolus coverage, and addressing family dynamics. In this vignette, morning hyperglycemia, high HbA1c, unbolused snacking, and inconsistent supervision due to divorce highlight the management challenges and considerations for type 1 diabetes. Choice B is correct because it aligns with current clinical guidelines for planned snacks with carb counting to prevent hyperglycemia. Choice A is incorrect because eliminating carbohydrates is unsustainable and risks nutritional deficits. To improve understanding, clinicians should discuss family support and monitoring strategies, focusing on key management principles like consistent bolusing and glucose trend analysis.
  13. Which medication adjustment is most appropriate?
    Answer: Switch to atomoxetine monotherapy to address ADHD without exacerbating tics When you encounter a patient with both ADHD and Tourette syndrome, you need to understand that stimulant medications like methylphenidate can exacerbate tics in some patients, even when ADHD symptoms remain well-controlled. This case presents the classic clinical dilemma of balancing ADHD treatment with tic management. The correct approach is A) Switch to atomoxetine monotherapy. Atomoxetine is a selective norepinephrine reuptake inhibitor that effectively treats ADHD without worsening tics. Unlike stimulants, atomoxetine doesn't affect dopamine pathways in the same way, making it the preferred first-line alternative when stimulants exacerbate tics in patients with comorbid Tourette syndrome. B) Adding risperidone while continuing methylphenidate creates unnecessary polypharmacy. While risperidone can help tics, it doesn't address the root problem that methylphenidate is likely causing the tic exacerbation. You'd be treating a medication side effect with another medication rather than switching to a more appropriate primary treatment. C) Increasing methylphenidate is counterproductive since stimulants typically worsen tics in a dose-dependent manner. Higher doses would likely make the tics even worse. D) Discontinuing all medications ignores that her ADHD symptoms are well-controlled and need continued treatment. Behavioral therapy alone is insufficient for moderate-to-severe ADHD requiring medication. Key takeaway: When stimulants worsen tics in ADHD patients with Tourette syndrome, switch to atomoxetine as first-line alternative therapy rather than adding antipsychotics or abandoning ADHD treatment entirely. This maintains ADHD control while addressing the tic exacerbation.
  14. Which intervention is most likely to improve this patient's long-term asthma control?
    Answer: Arrange a school-based directly observed therapy program for daily controller inhaler administration When you encounter pediatric asthma cases with poor control despite appropriate medications, always consider adherence barriers first. This 9-year-old shows classic signs of medication non-adherence: frequent oral steroid courses, suboptimal prescription refills, and a working mother who cannot supervise daily medication use. Choice A is correct because it directly addresses the root problem—inconsistent medication administration. School-based directly observed therapy ensures the child receives daily controller medication during school hours when the mother cannot supervise. This intervention removes the primary barrier to adherence while maintaining the child's current appropriate medication regimen. Choice B is wrong because stepping up therapy intensity without addressing adherence won't improve outcomes and increases cost and side effect risk. The current medication is appropriate; the issue is consistent use, not potency. Choice C (home nebulizer) doesn't solve the supervision problem—the mother still cannot ensure twice-daily administration due to her work schedule. Additionally, switching delivery methods without addressing adherence is unlikely to improve control. Choice D (monthly verbal reinforcement) is too passive and doesn't provide practical solutions for the family's structural barriers. Simply telling someone to take medication more consistently doesn't address the underlying obstacle of maternal unavailability. Key strategy: In pediatric medication adherence questions, look for interventions that address specific logistical barriers rather than simply intensifying treatment. School-based programs are particularly effective for working families where parental supervision is limited during traditional medication times.
  15. A 12-year-old girl with type 1 diabetes has 2 months of wide glucose swings (50–350 mg/dL) and fatigue; HbA1c 9.4%. She often skips breakfast, counts carbs inconsistently, and avoids bolusing at school due to embarrassment. She uses basal glargine nightly and rapid-acting insulin with meals but misses lunchtime doses 3–4 days/week. What is the next best step in management?
    Answer: Initiate a structured diabetes education plan with school support and adjust bolus dosing based on carb counting This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on type 1 diabetes. Effective management involves insulin therapy, carbohydrate counting, education, and addressing psychosocial barriers. In this vignette, wide glucose swings, high HbA1c, skipped meals, inconsistent carb counting, and school embarrassment highlight the management challenges and considerations for type 1 diabetes. Choice C is correct because it aligns with current clinical guidelines for structured education and school support to improve adherence and bolus dosing. Choice A is incorrect because decreasing basal insulin would not address the root causes of swings from missed boluses and poor carb counting. To improve understanding, clinicians should involve multidisciplinary teams for education and psychosocial support, focusing on key management principles like consistent monitoring and individualized plans. Additionally, empowering patients with school accommodations can enhance long-term control.
  16. An 8-year-old boy with repaired Tetralogy of Fallot has 2 months of reduced exercise tolerance. Echocardiogram shows right ventricular outflow tract dilation and moderate pulmonary regurgitation. He participates in sports without symptoms at rest. Which of the following is the most appropriate adjustment to the current treatment plan?
    Answer: Refer for evaluation of pulmonary valve intervention based on symptoms and right ventricular changes This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on repaired Tetralogy of Fallot. Effective management involves referral for valve intervention assessment. In this vignette, reduced exercise tolerance, RV dilation, moderate regurgitation, and sports participation highlight the management challenges and considerations for repaired Tetralogy of Fallot. Choice A is correct because it aligns with current clinical guidelines for evaluating symptomatic regurgitation. Choice C is incorrect because deferring follow-up risks progression. To improve understanding, clinicians should monitor for surgical indications, focusing on key management principles like activity guidance and imaging.
  17. Which of the following is the most appropriate next step in managing his obesity?
    Answer: Refer for evaluation for laparoscopic sleeve gastrectomy as a bariatric option When evaluating severe pediatric obesity with significant comorbidities, you need to consider the full spectrum of treatment options, including bariatric surgery for carefully selected adolescents who meet specific criteria. This patient meets several key criteria for bariatric surgery consideration: BMI >35 kg/m² with serious comorbidities (obstructive sleep apnea requiring CPAP, hypertension, and NAFLD), Tanner stage III indicating adequate pubertal development, and failure of comprehensive lifestyle interventions over 18 months. Current guidelines support bariatric surgery evaluation in adolescents meeting these strict criteria. Answer A is correct because laparoscopic sleeve gastrectomy is an appropriate first-line bariatric procedure for adolescents. Answer B is incorrect because orlistat is not FDA-approved for children under 12 years old, and even when used in adolescents, it typically produces only modest weight loss (3-5%) with significant gastrointestinal side effects. Answer C is wrong because while metformin might help with insulin resistance, it's not a primary obesity treatment and won't address this patient's severe weight-related comorbidities that require more aggressive intervention. Answer D is inappropriate because demanding 2 hours of vigorous daily exercise is unrealistic for a morbidly obese child with sleep apnea and could lead to injury or treatment failure. Remember that pediatric bariatric surgery isn't a first-line treatment—it's reserved for severe cases with significant comorbidities after lifestyle interventions have failed. Always look for the combination of extreme BMI, serious health consequences, pubertal maturity, and failed conservative management when considering surgical options.
  18. A 12-year-old girl with type 1 diabetes has 2 weeks of early-morning hypoglycemia (55–65 mg/dL). HbA1c is 7.4%. She recently increased evening physical activity and eats a smaller dinner. She takes glargine at bedtime and rapid-acting insulin with meals; adherence is good. Which medication should be initiated or adjusted?
    Answer: Reduce basal insulin dose and reassess overnight glucose trends with more frequent monitoring This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on type 1 diabetes. Effective management involves basal insulin adjustments based on trends. In this vignette, morning hypoglycemia, good HbA1c, increased activity, and smaller dinners highlight the management challenges and considerations for type 1 diabetes. Choice B is correct because it aligns with current clinical guidelines for reducing basal dose to prevent lows. Choice A is incorrect because increasing glargine would worsen hypoglycemia. To improve understanding, clinicians should review logs frequently, focusing on key management principles like activity adjustments and overnight monitoring.
  19. A 10-year-old boy with asthma has frequent albuterol use and 2 nighttime awakenings weekly for 2 months. Spirometry: FEV1 74% predicted. He uses low-dose inhaled corticosteroid daily but has continued symptoms; adherence is confirmed by pharmacy refill history. Family recently got a dog, and symptoms worsen at home. What is the next best step in management?
    Answer: Step up to medium-dose inhaled corticosteroid or add LABA and counsel on trigger reduction This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on asthma. Effective management involves therapy escalation and trigger mitigation. In this vignette, frequent symptoms, reduced FEV1, confirmed adherence, and new dog exposure highlight the management challenges and considerations for asthma. Choice A is correct because it aligns with current clinical guidelines for stepping up ICS or adding LABA in persistent asthma. Choice B is incorrect because stopping controllers would exacerbate symptoms. To improve understanding, clinicians should counsel on environmental controls, focusing on key management principles like stepwise therapy and allergen avoidance.
  20. A 12-year-old girl with type 1 diabetes reports frequent hypoglycemia during afternoon soccer practices for 1 month. Glucose logs show lows (50–70 mg/dL) after practice; HbA1c 7.9%. She takes rapid-acting insulin with lunch at school and often cannot finish her meal due to short lunch period. What is the most appropriate adjustment to the current treatment plan?
    Answer: Reduce or delay pre-exercise bolus insulin and ensure a carbohydrate snack before activity This question tests USMLE Step 2 CK competencies in managing chronic pediatric conditions, focusing on type 1 diabetes. Effective management involves insulin adjustments for activity and nutrition. In this vignette, hypoglycemia during soccer, postprandial lows, and short lunch periods highlight the management challenges and considerations for type 1 diabetes. Choice B is correct because it aligns with current clinical guidelines for reducing pre-exercise insulin and adding snacks. Choice E is incorrect because skipping activity limits physical health benefits. To improve understanding, clinicians should teach glucose monitoring around exercise, focusing on key management principles like individualized dosing and school coordination.

Start this quiz